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1 |  INTRODUCTION
Inflammatory bowel disease (IBD) manifests as two major 
types—Crohn's disease and ulcerative colitis—which are re-
lapsing chronic inflammatory disorders of the intestine. The 
incidence of IBD is rapidly increasing worldwide, with over 3 
million individuals in the United States with 70 000 new cases 
diagnosed each year.1 A number of common gastrointestinal 
disorders, including IBD, share a common impairment of the 
intestinal barrier function.2 This barrier consists of epithelial 
cells with intercellular junctions that link adjacent cells and 
seal the intercellular spaces.2 The barrier protects against the 
penetration of harmful solutes, microorganisms, toxins, and 
luminal antigens into the body, while acting as a selective 
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Abstract
Diet plays a significant role in the pathogenesis of inflammatory bowel disease 
(IBD). A recent epidemiological study has shown an inverse relationship between 
nutritional manganese (Mn) status and IBD patients. Mn is an essential micronutrient 
required for normal cell function and physiological processes. To date, the roles of 
Mn in intestinal homeostasis remain unknown and the contribution of Mn to IBD has 
yet to be explored. Here, we provide evidence that Mn is critical for the maintenance 
of the intestinal barrier and that Mn deficiency exacerbates dextran sulfate sodium 
(DSS)-induced colitis in mice. Specifically, when treated with DSS, Mn-deficient 
mice showed increased morbidity, weight loss, and colon injury, with a concomi-
tant increase in inflammatory cytokine levels and oxidative and DNA damage. Even 
without DSS treatment, dietary Mn deficiency alone increased intestinal permeability 
by impairing intestinal tight junctions. In contrast, mice fed a Mn-supplemented diet 
showed slightly increased tolerance to DSS-induced experimental colitis, as judged 
by the colon length. Despite the well-appreciated roles of intestinal microbiota in 
driving inflammation in IBD, the gut microbiome composition was not altered by 
changes in dietary Mn. We conclude that Mn is necessary for proper maintenance 
of the intestinal barrier and provides protection against DSS-induced colon injury.
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filter that permits the absorption of essential nutrients, elec-
trolytes, and water from the intestinal lumen and their release 
into the circulation.2 Impairment of the barrier function per-
mits the invasion of luminal bacteria into the lamina propria, 
thereby triggering an immune response and intestinal inflam-
mation.2 At present, no cure exists for IBD and treatment op-
tions are limited.
Complex interactions between genetic, environmental, mi-
crobial, and immune factors are believed to contribute to IBD 
disorders.3 The recent identification of >200 susceptibility 
loci that confer vulnerability to IBD in genome-wide associ-
ation studies4 has underscored the significant role of genet-
ics in IBD. However, while genetic risk factors clearly play a 
role, genetics contribute to only a small fraction of the disease 
risk. Environmental factors are also suspected as triggers and 
these may explain the weakly penetrant disease development. 
Indeed, dietary nutrients are now implicated in numerous ep-
idemiological and experimental studies as prominent factors 
that may play critical roles in IBD.5 Macronutrients, such as 
glucose and lipids, play a pivotal role in the development of 
IBD5; however, evidence now also points to a role for mi-
cronutrients in both disease development and treatment. To 
date, many micronutrients (eg, vitamins A, C, D, and E) and 
trace minerals (eg, iron (Fe), zinc (Zn), and selenium (Se)) 
have been implicated in the pathogenesis of IBD.6 However, 
one essential micronutrient, manganese (Mn), has yet to be 
explored as a risk factor for IBD.
Mn deficiency is rare in humans due to its availability in 
numerous dietary sources. Mn is abundant in plant-based 
foods, such as whole grains, legumes, rice, nuts, and vege-
tables, although it is relatively deficient in animal sources, 
including meat, fish, poultry, eggs, and dairy products.7 
However, low Mn levels have been reported in IBD patients. 
For example, a recent epidemiological survey measured hair 
micronutrient levels in pediatric patients newly diagnosed 
with Crohn's disease and ulcerative colitis from 2012 to 
2016.8 This study identified that Fe (P = .033), Se (P = .017), 
and Mn (P = .009) were significantly lower in patients with 
Crohn's disease and ulcerative colitis than in healthy controls, 
implicating insufficiency in these trace minerals, including 
Mn, as potential risk factors for IBD.
Mn is an essential micronutrient required for normal cell 
function and for a variety of physiological processes, such as 
bone growth, regulation of blood sugar and cellular energy 
levels, blood coagulation and hemostasis, and defense against 
reactive oxygen species (ROS).9 Mn directs cellular processes 
by acting as a cofactor in the reactions catalyzed by numer-
ous enzymes, including Mn superoxide dismutase (MnSOD), 
arginase, xanthine oxidase, galactosyltransferase, pyruvate 
decarboxylase, and glutamine synthetase.9 Some of the Mn-
related cellular processes, such as defense against ROS, have 
been implicated in IBD, suggesting that Mn may play a role 
in IBD pathogenesis. The goal of the present study was to 
determine the contribution of dietary Mn to IBD in a mouse 
model of dextran sulfate sodium (DSS)-induced colitis.
2 |  MATERIALS AND METHODS
2.1 | Animals and treatment conditions
Wild-type (WT) C57BL/6 mice aged 3-4  weeks were pur-
chased from Jackson Laboratory and maintained on a metal-
basal diet containing 35  mg Mn/kg (TD120518, Harlan 
Teklad, Indianapolis, IN, USA) (Table S1), as previously 
described.10,11 The trace element levels in the diet were as 
recommended by the American Institute of Nutrition.12 
For dietary Mn alterations, the mice were fed either Mn-
deficient, Mn-adequate, or Mn-supplemented diets (<0.01, 
35, and 300  ppm Mn, respectively; Harlan Teklad). The 
actual Mn concentrations of the diets were 0-0.5  ppm Mn 
(Mn-deficient), 35-35.5  ppm Mn (Mn-adequate), and 300-
301  ppm Mn (Mn-supplemented), as determined previ-
ously by inductively coupled plasma mass spectrometry 
(ICP-MS).13,14 For colitis induction, mice were provided 
with water containing 3% (w/v) DSS for 6 days (inflamma-
tory phase). The mice were then placed on regular drinking 
water for 7 days (recovery phase). All mice in the same ex-
periment were from an age-matched, co-housed cohort. This 
study was performed in strict accordance with the recom-
mendations in the Guide for the Care and Use of Laboratory 
Animals of the National Institutes of Health (Bethesda, MD, 
USA). The protocol (protocol number: PRO00008963) was 
approved by the University Committee on Use and Care of 
Animals (UCUCA) at the University of Michigan.
2.2 | RNA isolation and RT-PCR
Total RNA was isolated from colon mucosal cells using TRIzol 
reagent (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, 
MA, USA) following the manufacturer's instructions. Purified 
RNA was then reverse-transcribed with SuperScript III First-
Strand Synthesis System (Invitrogen; Thermo Fisher Scientific, 
Inc.). The RT-PCR was performed using the Power SYBR-
Green PCR Master Mix (Applied Biosystems; Thermo Fisher 
Scientific, Inc.). GAPDH was used for normalization of the 
mRNA. The primers used for qPCR are listed in Table S2 and 
were all purchased from Integrated Genomics Technologies.
2.3 | Immunoblot analysis
Colonic mucosal cells were scraped and lysed in RIPA buffer 
containing protease inhibitors (Roche, Basel, Switzerland; 
Cat. No. 11836153001). Protein concentrations were 
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determined with the Bradford assay. Samples (30-50  μg) 
were separated by electrophoresis and transferred to a nitro-
cellulose membrane (Bio-Rad, Hercules, CA, USA; Cat. No. 
1620115). The membrane was immunoblotted with anti-ZO-1 
antibody (Santa Cruz, Dallas, Texas, USA; Cat. No. 33725), 
anti-ZO-2 antibody (Santa Cruz; Cat. No. 515115), anti-Oc-
cludin antibody (Santa Cruz; Cat. No. 133256), anti-Claudin 
2 antibody (Santa Cruz; Cat. No. 293233), and anti-mouse 
actin (Proteintech, Rosemont, IL USA; Cat. No. 60008-1-Ig). 
The blots were visualized with infrared anti-mouse or anti-rat 
secondary antibodies, using an LI-COR Odyssey fluorescent 
western blotting system (LI-COR Biosciences, Lincoln, NE, 
USA). Protein expression was quantified by densitometry 
(Image Studio Lite; LI-COR).
2.4 | Histology and 
immunohistochemical staining
Colon tissues were fixed in 4% paraformaldehyde at 4°C 
overnight. H&E analysis was performed in paraffin-embed-
ded tissue sections (5 microns). The histological scoring was 
performed by a pathologist who blindly assessed the degree 
of surface epithelial loss, crypt destruction, and inflamma-
tory cell infiltration into the mucosa, resulting in a score 
from 0 to 12.
2.5 | Trace element analysis
Tissue samples were analyzed for metals by ICP-MS. 
Briefly, tissue samples taken from the mice were digested 
with 2  mL/g total wet weight nitric acid (BDH ARISTAR 
ULTRA) for 24 hours and then digested with 1 mL/g total 
wet weight hydrogen peroxide (BDH Aristar ULTRA) for 
24 hours at room temperature. Specimens were preserved at 
4°C until quantification of metals. Ultrapure water was used 
for the final sample dilution.
2.6 | Manganese superoxide dismutase assay
Mitochondrial MnSOD activity was determined using a 
Superoxide Dismutase Assay Kit (Cayman Chemical, Ann 
Arbor, MI, USA) as described previously.11,13 Briefly, the 
colonic mucosal cells were scraped into ice-cold MB buffer 
(10 mM HEPES, pH 7.5, 210 mM mannitol, 70 mM sucrose, 
and 1 mM EDTA) and then homogenized with a Dounce glass 
homogenizer. The cell extract was centrifuged at 1000 g for 
5 minutes at 4°C and the mitochondrial fraction was pelleted 
by centrifugation at 12 000 g for 12 minutes at 4°C. MnSOD 
activity was determined in the presence of 2 mM potassium 
cyanide to inhibit Cu/Zn-SOD.
2.7 | Isoprostane analysis
Isoprostane was chosen as a marker of oxidative damage and 
measured by a competitive enzyme-linked immunosorbent 
assay (ELISA) for one of the isoprostanes 8-iso Prostaglandin 
F2α (8-iso-PGF) with a commercial kit (Cayman Chemical, 
Ann Arbor, MI). The assay was based on the competition 
between 8-iso-PGF and 8-isoprostane-acetylcholinesterase 
(AChE) conjugate for a limited number of binding sites in 
each ELISA plate well. The concentration of 8-iso-PGF is in-
versely proportional to the number of binding sites available, 
whereas AChE is held constant. The assays were performed 
as previously described.13
2.8 | Measurement of oxidative 
DNA damage
Serum oxidative DNA damage was measured using a com-
mercial 8-hydroxy-2-deoxyguanosine (8-OHdG) ELISA 
assay kit (Cayman Chemical, Ann Arbor, MI) according to 
the manufacturer's protocol. Serum samples were diluted 
1:50 prior to analysis.
2.9 | Hydrogen peroxide assay
Tissue hydrogen peroxide levels were measured using a 
hydrogen peroxide assay kit (Abcam, Cambridge, United 
Kingdom), according to the instructions supplied by the 
manufacturer.
2.10 | Microbiota analysis
Fecal DNA was extracted using an EZNA stool DNA kit 
(Omega Bio-tek). Microbiota composition was determined by 
sequencing the V4 region of the 16S rRNA gene (≈250 bp) 
from the 5′ and 3′ ends with Illumina MiSeq and the resulting 
reads were assembled and analyzed by Mothur, as described 
previously.15 The OTUs were classified into taxonomic phy-
lotypes at >97% identity. The Shannon, Chao, and Simpson 
diversity indexes, Shannon evenness index, θYC, and Bray-
Curtis dissimilarity indexes were calculated by Mothur, 
whereas the operational taxonomic unit (OTU) richness was 
calculated by Microsoft Excel. An NMDS plot of β-diversity 
with the minimal stress value was generated and the LEfSe 
Linear discriminant analysis (LDA) values of the OTUs and 
the false discovery rate between two groups were determined 
by Mothur. Comparative marker selection was used to com-
plement the LEfSe analysis via GENE-E (https ://www.broad 
insti tute.org/cance r/softw are/GENE-E/) using the default set-
tings and 10,000 permutations.
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2.11 | Intestinal permeability assay
Fluorescein isothiocyanate (FITC)-dextran (4  kDa,  FD4; 
Sigma, St. Louis, MO, USA) was used as an indicator to 
examine barrier function. Briefly, mice were gavaged with 
FITC-dextran (40 mg/100 g body weight). Four hours later, 
the fluorescence intensity of the serum samples was meas-
ured. Serum was collected and the fluorescence intensity of 
each sample (excitation, 485  nm; emission, 525  nm) was 
measured using a BioTek Synergy microplate reader (BioTek 
Instruments, Winooski, VT). The FITC-dextran concentra-
tions were determined from standard curves generated by the 
serial dilution of FITC-dextran.
2.12 | Statistical analysis
Statistical analyses were performed using GraphPad Prism 
software version 8 (GraphPad Software Inc., La Jolla, CA, 
USA). PAST 3.22 was used for PERMANOVA calculation 
based on 9999 permutations. The Shapiro-Wilk normality 
test was used to test the assumption of normal distribution. 
Differences between two groups were evaluated using a 
two-tailed unpaired t test or the Mann-Whitney U test for 
normally or non-normally distributed datasets, respectively. 
The comparison of more than two groups was performed 
with one-way ANOVA, followed by the Dunnett's multi-
ple comparisons test for normally distributed datasets or by 
either the Kruskal-Wallis or Friedman test, both followed 
by the Dunn's multiple comparisons test, for data with non-
normal distributions. For highly repetitive comparisons 
between two groups, we also performed false positive rate 
analysis using the metastats command in Mothur, after the 
removal of the OTUs that were not included in the tested 
dataset. PERMANOVA was used for the analysis of the 
Bray-Curtis indexes for Figure 5. Differences at P < .05 and 
q < 0.05 were considered statistically significant.
3 |  RESULTS
3.1 | Mn deficiency exacerbates intestinal 
injury after DSS treatment
We explored the roles of Mn in colitis by first investigating 
whether dietary Mn alters the susceptibility to DSS-induced 
injury, which is characterized by robust epithelial denuda-
tion and inflammation.16 DSS damages the epithelial mon-
olayer that lines the large intestine, thereby allowing the 
proinflammatory intestinal contents to pass through the in-
testinal barrier.16 Mice were fed with either a Mn-deficient 
(<0.01 mg Mn per kilogram of diet) or Mn-adequate (35 mg 
Mn/kg) diet for 14 days, followed by treatment with DSS 
(Figure 1A). Two weeks on the Mn-deficient diet was suf-
ficient to induce intestinal Mn deficiency, as assessed by 
ICP-MS of the duodenum and colon tissues. The mice 
fed with Mn-deficient diet showed an 86-96% reduction in 
Mn levels in the duodenum and colon (Figure 1B,C). The 
levels of other trace elements, including Fe, Zn, and Cu, 
were not altered in these tissues (Figure 1B,C). Heavy met-
als, such as cadmium and lead, were not detected in these 
samples. We found no differences in body weights or food 
intake during the 2-week experimental period in the mice 
fed Mn-deficient and Mn-adequate diets (Figure 1D,E). 
These findings demonstrate that 2 weeks of dietary Mn de-
ficiency influenced Mn levels in the intestines without af-
fecting other trace element levels.
Having established a condition that achieved dietary 
Mn deficiency, we treated mice fed either Mn-deficient or 
Mn-adequate diets with 3% DSS in the drinking water to 
induce colitis (inflammatory phase) (Figure 1A). The mice 
were then placed on regular drinking water for 7 days (re-
covery phase) (Figure 1A). During the monitoring phases, 
the mice continued to receive the same Mn diets. The mice 
fed with Mn-adequate diet and subjected to DSS treatment 
underwent profound and sustained weight loss, indicative of 
increased susceptibility to colitis (Figure 2A). Notably, the 
Mn-deficient mice displayed an even more enhanced body-
weight loss when compared to the Mn-adequate mice (Figure 
2A). When placed back on regular water, the Mn-adequate 
mice recovered their original body weights, whereas the 
Mn-deficient mice did not show any recovery and continued 
to lose body weight until the experimental endpoint (Figure 
2A). Most of the Mn-adequate mice survived the DSS treat-
ment, whereas approximately 60% of the Mn-deficient mice 
died by Day 13 (Figure 2B). The Mn-deficient mice also 
showed an approximately 13% decrease in colon length 
when compared with the Mn-adequate mice (Figure 2C,D). 
The ratio of the spleen to body weight was higher in the 
Mn-deficient mice than in the Mn-adequate mice, although 
this trend did not reach statistical significance (P  =  .055, 
Figure 2E). These data demonstrate that dietary Mn defi-
ciency exacerbates intestinal injury in this mouse model of 
DSS-induced colitis.
3.2 | Elevated inflammation in Mn-deficient 
mice in response to DSS
The administration of DSS in the drinking water causes 
intestinal epithelial injury and robust inflammatory re-
sponse.16 Histological analysis of the colons of the Mn-
deficient mice revealed increased tissue damage, including 
severe surface epithelial loss, crypt destruction, massive 
infiltration of inflammatory cells, and extensive degen-
eration of the epithelial structure (Figure 3A). The total 
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pathological score, which takes into account the surface 
epithelial loss, crypt destruction, and inflammatory cell 
infiltration into the mucosa, was significantly higher in 
the colons of Mn-deficient mice than in the colons of Mn-
adequate mice (Figure 3B). Chemokine and cytokine sign-
aling were also aberrantly regulated in the Mn-deficient 
mice in response to intestinal injury. The Mn-deficient 
mice showed significantly higher expression of chemokines 
Ccl2 and Cxcl1 and of inflammatory cytokines Tnfα, Il6, 
I11β, and Il10 (Figure 3C). Taken together, these data dem-
onstrate that dietary Mn deficiency exacerbates intestinal 
inflammation in DSS-induced colitis in mice.
F I G U R E  1  Dietary Mn deficiency reduces intestinal Mn levels. A, Schematic of the DSS-induced colitis model. Mice were fed with either 
Mn-deficient (Mn-D) or Mn-adequate (Mn-A) diets (0 and 35 mg/kg Mn, respectively). For colitis induction, mice were provided with drinking 
water containing 3% (w/v) DSS for 6 days (inflammatory phase). The mice were then provided with regular drinking water for 7 days (recovery 
phase). B and C, Levels of the trace elements manganese (Mn), iron (Fe), zinc (Zn), and copper (Cu) were measured by ICP-MS in the (B) 
duodenum and (C) colon of mice (n = 3-4 per group). D, Body weight changes (n = 10-11 per group) and (E) daily food intake (n = 4 per group) 
were assessed. Data represent means ± SEM. ***P < .001 
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3.3 | Intestinal permeability is increased in 
Mn-deficient mice in response to DSS
Increased intestinal permeability caused by dysfunctions of 
the intestinal barrier is a key cellular mechanism underly-
ing DSS-induced colitis and human IBD.16 We measured 
intestinal permeability in our mouse colitis model using 
FITC-dextran. Notably, the serum FITC-dextran levels on 
Day 6 of DSS treatment were significantly higher in the Mn-
deficient mice than in the Mn-adequate mice, indicating an 
increased intestinal permeability associated with Mn defi-
ciency (Figure 4A).
One possible mechanism that might mediate this ef-
fect could be an impairment of the mucosal barrier.17 DSS 
treatment is known to decrease the expression of tight 
junction proteins, which then leads to subsequent increases 
in the permeability of the mucosal barrier.16 Therefore, we 
examined the expression of the key components of colon 
epithelial tight junctions, as these structures can directly 
affect intestinal permeability. RT-PCR quantification 
showed substantial reductions in the gene expression of 
tight junction components (Zo1, Zo2, Cldn2, Cldn3, and 
Ocln) in the colon mucosa of the Mn-deficient mice after 
DSS treatment (Figure 4B). In contrast, the expression 
of Cldn4, 5, 7, 12, and 15 did not change, suggesting a 
selective impact of Mn deficiency on tight-junction gene 
expression.
We also examined colon epithelial adherens junctions, 
as these indirectly regulate the integrity of tight junctions.18 
Among the examined genes that encode adherens junction 
components, the expression of the cadherin gene Cdh1 was 
reduced in Mn-deficient mice after DSS treatment, whereas 
the level of Nectin1 was unchanged (Figure 4C). Further anal-
ysis by immunoblotting revealed diminished levels of Zonula 
occludens1 (ZO1), ZO2, Claudin2 (CLDN2), and Occludin 
(OCLN) in Mn-deficient animals (Figure 4D,E). These data 
demonstrated that Mn deficiency reduced the expression of 
a subset of tight junction and adherens junction components 
in the colon and indicated that these changes may underlie 
the increased intestinal permeability observed in DSS-treated 
mice. These findings suggest that Mn deficiency exacerbates 
the impairment of the intestinal barrier in the DSS-induced 
colitis model.
F I G U R E  2  Mn deficiency exacerbates intestinal injury in a mouse model of DSS-induced colitis. A, Body weight changes over time. Mice 
were provided with drinking water containing 3% DSS (w/v) for 6 days, followed by 7 days of regular drinking water. Body weight was measured 
over 13 days (n = 15 per group). B, Survival percentage (%) over time. C, Gross morphology of the large intestine. D, Colon length, and E, spleen/
body weight ratios at 6 days after the DSS treatment in mice fed Mn-adequate (Mn-A) or Mn-deficient (Mn-D) diets (n = 6-8 per group). Data 
represent means ± SEM. *P < .05 
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3.4 | Mn deficiency induces oxidative 
damage after DSS treatment
DSS-induced intestinal injury results in an increase in 
oxidative stress, which is at least partly attributable to 
immune cell infiltration and the release of inflammatory 
mediators.19 Increases in immune cell infiltration and in-
flammation were evident in the Mn-deficient mice after 
DSS treatment (Figure 3). Therefore, we next determined 
whether a Mn-deficient diet might reduce the activity of 
a specific Mn-requiring enzyme, manganese superoxide 
dismutase (MnSOD). MnSOD is a potent antioxidant en-
zyme located in the mitochondria. We first isolated mito-
chondria from the colons of DSS-treated mice fed either 
Mn-deficient or Mn-adequate diets and measured MnSOD 
activity. The MnSOD activity after DSS treatment was ap-
proximately 57% lower in the colons of Mn-deficient mice 
than in Mn-adequate mice (Figure 4F).
We then determined whether the observed reduction 
in cellular MnSOD activity involved altered production 
of ROS. Measurement of H2O2 levels in colon extracts 
revealed significantly higher H2O2 levels in the colons of 
Mn-deficient mice than in Mn-adequate mice (Figure 4G). 
We also measured oxidative stress by determining the lev-
els of two biomarkers: 8-isoprostane and 8-hydroxy-2′-de-
oxyguanosine (8-OHdG). The 8-isoprostane biomarker is 
a prostaglandin (PG)-F2-like compound produced by the 
free radical-catalyzed peroxidation of arachidonic acid.20 
The levels of 8-isoprostane after DSS administration were 
significantly higher in the Mn-deficient than in the Mn-
adequate mice (Figure 4H), indicating that Mn protects 
against lipid peroxidation in this mouse colitis model. The 
8-OHdG biomarker is excreted during the repair of DNA 
damage, thereby providing a quantitative index of oxidative 
DNA damage.21 The 8-OHdG levels were significantly in-
creased in the serum of Mn-deficient mice after DSS injury 
F I G U R E  3  Intestinal injury and inflammation are enhanced in Mn-deficient mice after DSS injury. A, Representative hematoxylin/eosin 
(H&E) staining of colons and (B) histological scores in Mn-adequate (Mn-A) or Mn-deficient (Mn-D) mice at 13 days after the DSS treatment 
(n = 5-9 per group). C, RT-PCR quantification of proinflammatory cytokines and chemokines in colon mucosa on Day 6 after DSS treatment 
(n = 4-6 per group). Data represent means ± SEM. *P < .05; ***P < .001 
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(Figure 4I), indicating that Mn protects against oxidative 
stress-associated DNA damage in this mouse colitis model. 
Mn deficiency, therefore, reduced cellular MnSOD activity 
and increased oxidative stress in the mouse model of DSS-
induced colitis.
3.5 | Dietary Mn alterations did not 
affect the microbiome composition in the colon
Diet is an important mediator of the microbial community 
structure.22 IBD is associated with a perturbation of gut 
microbiota (dysbiosis) characterized by reduced bacterial 
diversity. These changes include a reduced abundance of 
bacteria of the phyla Bacteroidetes and Firmicutes and en-
richment of bacteria of the family Enterobacteriaceae.23 
Dysbiosis is a key factor driving inflammation in IBD.24 
However, the effect of dietary Mn on gut microbiota and the 
contribution of dietary Mn on the development of dysbiosis 
have yet to be explored. Here, we determined whether di-
etary Mn alterations can alter the microbiome composition 
in the colon. To ensure a uniform and normalized micro-
biota composition, we first co-housed 4-week-old mice and 
fed them a Mn-adequate diet (35 mg/kg Mn) for 28 days. 
F I G U R E  4  Mn deficiency increases intestinal permeability and oxidative stress in the mouse model of DSS-induced colitis. A, Colitis was 
induced in Mn-adequate (Mn-A) or Mn-deficient (Mn-D) mice by the administration of DSS for 6 days and then FITC-dextran was administered by 
oral gavage 4 h before sacrifice. Fluorescence was then measured in collected serum samples (n = 5 per group). B and C, RT-PCR quantification of 
(B) tight junction and (C) adherens junction components in colon mucosal cells of Mn-D or Mn-A mice on Day 6 after DSS treatment (n = 4-6 per 
group). D, Representative immunoblots of tight junction protein expression in purified colon epithelial cells from Mn-A or Mn-D mice at 6 days 
after the DSS treatment. Immunoblots of actin were used as the loading control. E, Quantification of relative protein expression after normalization 
with actin (n = 3 per group). F, MnSOD activity was determined in mitochondria isolated from colon mucosal cells of mice after DSS injury. 
G, H2O2 levels in the colon mucosa, as well as oxidative damage determined by levels of (H) 8-isoprostane in colon mucosa or (I) 8-OHdG in 
serum, were measured in Mn-adequate (Mn-A) or Mn-deficient (Mn-D) mice on 6 days after the DSS treatment (n = 3-5/group). Data represent 
means ± SEM. *P < .05; **P < .01; ***P < .001 
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We then divided the mice into groups and fed them either 
a Mn-deficient (<0.01 mg/kg Mn), Mn-adequate (35 mg/
kg Mn), or Mn-supplemented (300 mg/kg Mn) diet for a 
further 14 days (Figure 5A). No signs of toxicity were ob-
served during this period.
We examined the effect of dietary Mn on the gut mi-
crobiota by collecting feces at the baseline (Day 0) and 
the end of the Mn manipulation (Day 14) and then deter-
mining the microbiota composition by Illumina 16S rRNA 
gene sequencing. The α diversity, as an indicator of species 
diversity in each sample, was determined based on Chao, 
Shannon diversity, and the evenness indexes, as well as the 
OTU richness, were similar among the three groups at Day 
0 and Day 14 (Figure 5B,C, see Table S3). The β-diversity, 
2938 |   CHOI et al.
determined by the theta YC (θYC) and Bray-Curtis dissim-
ilarity index (BC), which measure the diversity in the mi-
crobial community, showed no significantly distinct fecal 
microbiota differences in the three mouse groups at Day 0 
and Day 14 (Figure 5D, see Table S4). The abundance of 
individual OTUs in the fecal microbiota did not signifi-
cantly differ between the three groups, as determined by 
linear discriminant analysis effect size (LEfSe) analysis, 
followed by false discovery rate and family-wise error rate 
analyses (q > 0.05) (see Tables S5 and S6). These results 
indicate that dietary Mn alterations did not significantly 
change the gut microbiome composition in mice fed diets 
differing in their concentrations (0, 35, and 300 mg/kg) of 
Mn.
3.6 | Dietary Mn deficiency 
predisposes the colon to impairment of 
epithelial tight junction functions and 
oxidative damage
In our experimental paradigm, mice were fed a Mn-
deficient diet two weeks prior to the induction of DSS-
mediated colitis (Figure 1A). Mn deficiency increased the 
appearance of key pathological hallmarks of IBD (ie, Mn 
deficiency increased inflammation, oxidative stress, and 
epithelial permeability); however, the possibility remained 
that dietary Mn deficiency itself could influence these pa-
rameters, thereby predisposing animals to a more severe 
form of colitis. We, therefore, examined the effects of Mn 
deficiency alone, without DSS treatment, on epithelial 
tight junction functions.
Mn-deficient mice showed significantly increased expres-
sion of the chemokines Ccl2 and Cxcl1, but showed no signif-
icant change in cytokines Tnfα, Il6, Il1β, and Il10 (Figure 6A). 
The FITC-dextran experiments confirmed that a Mn-deficient 
diet alone could increase colon tissue permeability (Figure 
6B). We also found substantial reductions in the gene expres-
sion of tight junction components, such as Zo1, Zo2, Cldn2, 
and Cldn3, in the colon mucosa of Mn-deficient mice, even 
in the absence of DSS treatment (Figure 6C). Unlike the ef-
fects observed in DSS-treated mice (Figure 4B), occludin ex-
pression was not altered by Mn deficiency. No changes were 
detected in the gene expression of the adherens junction com-
ponents Cdh1 and Nectin1 (Figure 6D). Immunoblot analysis 
confirmed the diminished levels of the tight junction proteins 
ZO1, ZO2, CLDN2, but not of OCLN, in Mn-deficient mice 
(Figure 6E,F).
Measurements of key parameters of oxidative damage 
in vivo revealed a significantly lower MnSOD activity in 
the colons of Mn-deficient mice than in Mn-adequate mice 
(Figure 6G). Similarly, H2O2 production (Figure 6H) and 
the levels of the oxidative stress marker 8-isoprostane were 
significantly higher in the colons of Mn-deficient mice 
(Figure 6I). Comparison of these measurements with the 
DSS-induced IBD model (Figure 4) indicated that DSS 
treatment exacerbated the oxidative stress caused by Mn 
deficiency. Taken together, these findings indicate that 
dietary Mn deficiency itself impairs the intestinal epi-
thelial tight junctions and increases oxidative damage, 
thereby predisposing the colon to intestinal injury and 
inflammation.
3.7 | Mn supplementation increased 
tolerance in response to DSS treatment
We examined the role of Mn in colitis in greater detail by 
investigating whether dietary Mn supplementation alters the 
susceptibility to DSS-induced injury. Mice were fed either a 
Mn-adequate (35 mg/kg Mn) or Mn-supplemented (300 mg/
kg Mn) diet for 14  days, followed by treatment with 3% 
DSS in the drinking water to induce colitis (inflammatory 
phase) (Figure 7A). The mice were then placed on regular 
drinking water for 7  days (recovery phase) (Figure 7A). 
During the monitoring phases, the mice continued to receive 
the same Mn diet. Over the period of DSS treatment, the 
body weights of the two groups did not differ significantly 
F I G U R E  5  Effect of dietary Mn alterations on the gut microbiota. A, Schematic of dietary Mn alterations. Four-week-old mice were  
co-housed and fed a Mn-adequate diet (35 mg/kg Mn) for 28 days and then fed with either Mn-deficient, Mn-adequate, or Mn-supplemented diets 
(0, 35, or 300 mg/kg Mn, respectively) for 14 days. The composition of the fecal microbiota was analyzed on Day 0 and Day14 (indicated by green 
diamonds) (n = 10-12 per group). B, Relative abundance of dominant bacterial families in feces collected from mice fed different diets on Day 0 
and Day 14. C, The α diversity, including Chao, Shannon diversity, Shannon evenness, and OTU richness indexes, of fecal microbiota composition 
from mice fed different diets on Day 0 and Day 14. Data represents means ± SEM for Chao, Shannon diversity, and OTU richness indexes. Boxes 
represent the interquartile range between the first and third quartiles (25th and 75th percentiles, respectively), the horizontal line inside the box 
defines the median, and whiskers represent the lowest and highest values for Shannon evenness. NS = not significant; the Shapiro-Wilk normality 
test, followed by the Kolmogorov-Smirnov test, normality test. D, NMDS plot of β-diversity values (θYC indexes) of microbiota in fecal pellets 
from mice fed different diets on Day 0 and Day 14 is shown with the minimal stress (stress = 0.144335) after 1,000 iterations (n = 10 per group). 
Overall, no significant difference was noted in β-diversity between microbiota between different groups on Day 0 and Day 14 with P > .05 
(permutational multivariate analysis of variance [PERMANOVA]). See Tables S4-S6 
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(P =  .22, Figure 7B). However, significantly longer colon 
lengths were observed in the Mn-supplemented mice than in 
the Mn-adequate mice (Figure 7C), suggesting an alleviation 
of DSS-induced colitis. These data indicate that dietary Mn 
supplementation may be slightly protective against DSS-
induced experimental colitis.
F I G U R E  6  Intestinal permeability and oxidative stress increase with dietary Mn deficiency. A, RT-PCR quantification of proinflammatory 
cytokines and chemokines in colon mucosa from Mn-adequate (Mn-A) or Mn-deficient (Mn-D) mice on Day 14 (n = 4 per group). B, Mice 
fed either Mn-A or Mn-D diets for 2 weeks were administered FITC-dextran by oral gavage 4 h before euthanasia. Serum was prepared and 
fluorescence was measured (n = 5-6 mice per group). C and D, RT-PCR quantification of (C) tight junction and (D) adherens junction components 
in colon mucosa (n = 4-6 mice per group). E, Representative immunoblots of tight junction protein expression in purified colon epithelial cells. 
Actin was used as a loading control. F, Quantification of relative protein expression after normalization with actin (n = 3 per group). G, MnSOD 
activity was determined in mitochondria isolated from colon mucosal cells in Mn-adequate (Mn-A) or Mn–deficient (Mn-D) mice. H, H2O2 levels, 
as well as (I) oxidative damage determined by 8-isoprostane levels in the colon mucosa were measured from in Mn-A or Mn-D mice (n = 5-6 per 
group). Data represent means ± SEM. *P < .05; **P < .01 
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3.8 | Discussion
This study provides the first evidence that dietary Mn de-
ficiency exacerbates intestinal injury and inflammation in 
an experimental colitis model. Our results provide some 
mechanistic insights into IBD, as they revealed how di-
etary Mn can maintain the intestinal barrier integrity 
and limit the development of colitis during colon injury. 
Micronutrient deficiencies have been, for decades, a major 
concern in the management of IBD as numerous studies 
have documented associations between IBD and deficien-
cies in trace minerals, such as Fe, Zn, and Se.25 Fe defi-
ciency is associated with the bleeding, malabsorption, or 
anemia that occurs in one-third of IBD patients,26 while 
zinc deficiency is also common in patients with IBD (15 
to 40% of the patient population).27 Similarly, an inverse 
association has been reported for nutritional Se status and 
the occurrence of IBD.28 These previous studies are remi-
niscent of the findings described here for Mn, as deficien-
cies in these other trace minerals also show effects on the 
intestinal barrier and immune functions.25
One striking feature of Mn deficiency was its impact on 
the severity of DSS-induced colitis. Previous studies using 
Se-deficient diets (<0.01  mg/kg) showed that a time pe-
riod of 12 weeks was required before Se deficiency resulted 
in any worsening in the colons of DSS-induced colitis in 
mice.29 In contrast, rats fed a zinc-deficient diet (5 mg/kg) 
for 3 weeks showed exacerbation of DSS-induced colitis.30 
In the present study, dietary Mn deficiency worsened the 
severity of experimental colitis and promoted IBD de-
velopment in mice after feeding a low Mn diet for only 
2 weeks, and the DSS treatment often led to death of the 
Mn-deficient animals (Figure 2). Our data underscore the 
crucial role of dietary Mn in maintaining intestinal muco-
sal homeostasis and suppressing IBD.
DSS-induced colitis resembles human ulcerative colitis 
with respect to the impaired barrier function.31 DSS treat-
ment of mice causes epithelial cell injury and a resulting 
immune response that can alter the mucosal barrier func-
tion throughout the colon epithelium32 and increase muco-
sal permeability.33 The DSS model is, therefore, an excellent 
model for investigating the effects of Mn on mucosal barrier 
function. Our use of this model confirmed that Mn-deficient 
mice displayed an increased intestinal permeability and im-
paired expression of tight junction proteins when compared 
to Mn-adequate mice. Strikingly, even in the absence of 
DSS treatment, mice fed with a Mn-deficient diet displayed 
a 1.5-fold greater permeability and impaired expression of 
tight junction proteins when compared with mice fed a Mn-
adequate diet (Figure 6). These data suggest that impairment 
of the intestinal barrier in response to a Mn-deficient diet 
makes the mice more susceptible to severe intestinal injury 
F I G U R E  7  Dietary Mn supplementation increases tolerance in response to DSS treatment. A, Schematic of the DSS-induced colitis model. 
Mice were fed with either Mn-adequate (Mn-A) or Mn-supplemented (Mn-S) diets (35 and 300 mg/kg Mn, respectively). For colitis induction, 
mice were provided with drinking water containing 3% (w/v) DSS for 6 days (inflammatory phase). The mice were then placed on regular drinking 
water for 7 days (recovery phase). B, Body weight changes over time. Mice were treated with 3% DSS in drinking water for 6 days, followed by 
7 days of regular drinking water. Body weight was measured over the entire 13 day period (n = 15 per group). C, Colon length from mice fed 
Mn-adequate (Mn-A) or Mn-supplemented (Mn-S) diets on Day 6 after DSS treatment (n = 4-5 per group). Data represent means ± SEM. *P < .05 
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and inflammation following DSS administration. Studies are 
currently underway using acute and chronic colitis models to 
define the crucial role of Mn in IBD and to identify the mech-
anism by which Mn drives inflammation and compromises 
the intestinal barrier function.
Diet affects the composition of the human gut microbi-
ome and its microbial metabolites.34 The gut microbiome 
plays a crucial role in the pathogenesis of IBD; for exam-
ple, infusion of intestinal luminal contents into an excluded 
ileum triggers postoperative recurrence in Crohn's disease 
patients.35 Microbial colonization is required for the devel-
opment of active inflammation in the mouse model of DSS-
induce colitis and in IL-10 deficient mice.36,37 Increased 
dietary heme Fe intake by mice has also been associated with 
marked changes in the composition of the gut microbiota.38 
In contrast, depletion of luminal Fe can alter the gut micro-
bial composition and trigger inflammation in a mouse model 
of Crohn's disease.39 Our study is the first to assess whether 
alterations in dietary Mn alone are associated with changes in 
the composition of gut microbiota and whether these changes 
affect intestinal permeability and the development of intes-
tinal inflammation. We found that feeding diets containing 
different concentrations of Mn (0, 35, or 300 mg/kg Mn) for 
2 weeks did not change the composition of the mouse gut mi-
crobiome. One possibility is that a 2-week period of dietary 
Mn alteration may be insufficient to induce changes in the 
composition of the gut microbiota. Future studies should ad-
dress whether a longer duration of dietary Mn alteration can 
change the microbiome composition.
Interestingly, Fe, Zn, and Se are abundant in animal foods, 
such as red meats, seafood, and poultry, whereas Mn is es-
sentially absent from these foods and must be obtained from 
plant sources. As society has become industrialized, foods 
associated with the typical Western diet, characterized by 
high intakes of red meat, sugary desserts, high-fat foods, 
and refined grains, have replaced traditional plant-based, 
and therefore, Mn-adequate diets, leading to consumption 
of foods low in Mn.7 Epidemiological studies have revealed 
a >40% reduction in a dietary Mn consumption in the past 
15  years in the United States7,40,41 and a similar substan-
tial decline in Mn consumption has been reported in China 
within the last 14 years42,43 and in South Korea within the last 
6 years.44,45 These studies are congruent with an increasing 
incidence of IBD in developed countries46 and they indicate 
that, despite the rarity of dietary Mn deficiency (ie, the lack 
of Mn) regardless of dietary lifestyle, a Mn insufficiency is 
prevalent. Our data clearly demonstrated that tissue Mn de-
ficiency occurs in a rapid and robust manner. Therefore, we 
postulate that reductions in dietary Mn intake might be one 
of the contributing factors that would explain the observed 
worldwide increases in IBD incidence. Future study should 
address whether dietary Mn might provide dose-dependent 
protection against IBD.
Epidemiological data have shown lower Mn levels in pe-
diatric patients newly diagnosed with Crohn's disease or ul-
cerative colitis,8 which suggests that Mn deficiency may be 
one of the potential risk factors for pediatric IBD. Nutrition is 
a critical factor in the onset and treatment of pediatric IBD.47 
There is increasing evidence to suggest that dietary habits 
such as high consumption of animal proteins, fatty foods, and 
sugary desserts may predispose patients to the onset of pedi-
atric IBD.47 Our study suggests that a Mn-rich, plant-based 
diet might protect the colonic mucosa against inflammation 
in pediatric patients with IBD. Thus, an assessment of pa-
tients’ nutritional Mn status may be beneficial for making 
recommendations regarding dietary habits to those at a high 
risk of IBD, especially among the pediatric population. No 
formal recommended dietary allowance for Mn exists. The 
Institute of Medicine's Dietary Reference Intake for Mn cites 
~2 mg/day as adequate for adults and 1.2-1.5 mg/day as ad-
equate for children. The Dietary Reference Intake also lists 
9-11 mg/day of Mn for adults and 2-6 mg/day for children 
as the upper tolerable limit likely to pose no risk of adverse 
effects.48 However, the guidelines were set for healthy indi-
viduals and it remains unclear whether these numbers apply 
to the restoration of a severely injured gastrointestinal tract 
associated with low Mn in IBD patients.
Our work suggests that the restoration of nutritional Mn 
status to the normal range could be useful in the prevention 
and/or abrogation of IBD. One might argue that Mn toxic-
ity can be a concern for this type of strategy; however, most 
Mn toxicity is triggered by the inhalation of Mn dust in oc-
cupational settings, such as is reported in workers employed 
in Mn dioxide mines, smelters, steel manufacturing plants, 
and dry-cell battery factories.9 Thus, no evidence of dietary 
Mn toxicity has been found in humans.49 This is because the 
homeostatic regulation of dietary Mn levels is tightly con-
trolled by intestinal absorption and hepatobiliary excretion 
of the nutrient.50 Unlike dietary sources of Mn, airborne Mn 
circumvents the first-pass clearance mechanisms. Therefore, 
inhaled Mn is effectively transported across the air-brain bar-
rier, thereby potentially leading to brain Mn accumulation. In 
our Mn supplementation study, we fed mice with 300 ppm 
Mn and found a slight protective effect against DSS-induced 
colitis. Previous mouse studies have shown that oral supple-
mentation with Mn even at levels of ~2400  ppm does not 
cause toxicity.51,52 This finding suggests that Mn toxicity 
would be less of a concern in the design of dietary Mn sup-
plementation for this IBD mouse model. Future studies will 
be needed to determine the dietary Mn levels that would be 
most beneficial for human patient populations.
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